(Q36515221)

14 August 2017

1 reference

title

Neurochemical actions of CCK underlying the therapeutic potential of CCK-B antagonists (English)

1 reference

14 August 2017

1 reference

https://api.crossref.org/works/10.1016/0143-4179(91)90087-Y

27 October 2022

1 reference

https://api.crossref.org/works/10.1016/0143-4179(91)90087-Y

27 October 2022

author name string

J. Hughes

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1679213

27 October 2022

J. C. Hunter

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1679213

27 October 2022

G. N. Woodruff

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1679213

27 October 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1679213

27 October 2022

publication date

1 July 1991

1 reference

full work available at URL

14 August 2017

https://api.elsevier.com/content/article/PII:014341799190087Y?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0143-4179(91)90087-Y

https://api.elsevier.com/content/article/PII:014341799190087Y?httpAccept=text/plain

27 October 2022

1 reference

https://api.crossref.org/works/10.1016/0143-4179(91)90087-Y

27 October 2022

1 reference

14 August 2017

volume

19 Suppl

1 reference

14 August 2017

page(s)

85-89

1 reference

Development of a class of selective cholecystokinin type B receptor antagonists having potent anxiolytic activity

14 August 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0143-4179(91)90087-Y

PD134308, a selective antagonist of cholecystokinin type B receptor, enhances the analgesic effect of morphine and synergistically interacts with intrathecal galanin to depress spinal nociceptive reflexes

27 October 2022

2

1 reference

https://api.crossref.org/works/10.1016/0143-4179(91)90087-Y

A subpopulation of mesencephalic dopamine neurons projecting to limbic areas contains a cholecystokinin-like peptide: evidence from immunohistochemistry combined with retrograde tracing

27 October 2022

3

1 reference

https://api.crossref.org/works/10.1016/0143-4179(91)90087-Y

Heterogeneity of GABAergic cells in cat visual cortex

27 October 2022

4

1 reference

https://api.crossref.org/works/10.1016/0143-4179(91)90087-Y

Cholecystokinin potentiates dopamine-mediated behaviors: evidence for modulation specific to a site of coexistence

27 October 2022

5

1 reference

https://api.crossref.org/works/10.1016/0143-4179(91)90087-Y

Facilitation of GABA release by cholecystokinin and caerulein in rat cerebral cortex

27 October 2022

7

1 reference

https://api.crossref.org/works/10.1016/0143-4179(91)90087-Y

The actions of cholecystokinin and related peptides on pyramidal neurones of the mammalian hippocampus

27 October 2022

8

1 reference

https://api.crossref.org/works/10.1016/0143-4179(91)90087-Y

Effects of cholecystokinin and related peptides on neuronal activity in the ventromedial nucleus of the rat hypothalamus

27 October 2022

9

1 reference

https://api.crossref.org/works/10.1016/0143-4179(91)90087-Y

In vivo and in vitro effects of cholecystokinin on gonadotropin, prolactin, growth hormone and thyrotropin release in the rat

27 October 2022

10

1 reference

https://api.crossref.org/works/10.1016/0143-4179(91)90087-Y

Adrenocortical stimulation by a cholecystokinin preparation in the rat

27 October 2022

11

1 reference

https://api.crossref.org/works/10.1016/0143-4179(91)90087-Y

Influence of bombesin, CCK, secretin and CRF on corticosterone concentration in the rat.

27 October 2022

12

1 reference

https://api.crossref.org/works/10.1016/0143-4179(91)90087-Y

Modulation of hypothalamic cholecystokinin receptor density with changes in magnocellular activity: a quantitative autoradiographic study

27 October 2022

13

1 reference

https://api.crossref.org/works/10.1016/0143-4179(91)90087-Y

The effect of anteroventral third ventricular lesions on the changes in cholecystokinin receptor density in the rat supraoptic nucleus following saline drinking

27 October 2022

14

1 reference

https://api.crossref.org/works/10.1016/0143-4179(91)90087-Y

Oxytocin secretion in response to cholecystokinin and food: differentiation of nausea from satiety

27 October 2022

15

1 reference

https://api.crossref.org/works/10.1016/0143-4179(91)90087-Y

Vasopressin release in response to nausea-producing agents and cholecystokinin in monkeys

27 October 2022

16

1 reference

https://api.crossref.org/works/10.1016/0143-4179(91)90087-Y

Effect of cholecystokinin octapeptide on endogenous amino acid release from the rat ventromedial nucleus of the hypothalamus and striatum

27 October 2022

17

1 reference

https://api.crossref.org/works/10.1016/0143-4179(91)90087-Y

Cholecystokinin modulation of [3H]noradrenaline release from superfused hypothalamic slices

27 October 2022

18

1 reference

https://api.crossref.org/works/10.1016/0143-4179(91)90087-Y

CCK nerve terminals in the rat striatal and limbic areas originate partly in the brain stem and partly in telencephalic structures

27 October 2022

19

1 reference

https://api.crossref.org/works/10.1016/0143-4179(91)90087-Y

Origin of the cholecystokinin-containing fibers in the rat caudatoputamen

27 October 2022

21

1 reference

https://api.crossref.org/works/10.1016/0143-4179(91)90087-Y

Cholecystokinin modulates the release of dopamine from the anterior and posterior nucleus accumbens by two different mechanisms

27 October 2022

25

1 reference

https://api.crossref.org/works/10.1016/0143-4179(91)90087-Y

Topographical analysis of nucleus accumbens sites at which cholecystokinin potentiates dopamine-induced hyperlocomotion in the rat.

27 October 2022

26

1 reference

https://api.crossref.org/works/10.1016/0143-4179(91)90087-Y

Neurochemical actions of CCK underlying the therapeutic potential of CCK-B antagonists

27 October 2022

27

1 reference

https://api.crossref.org/works/10.1016/0143-4179(91)90087-Y

Cholecystokinin releases [3H]GABA from the perfused subarachnoid space of the anaesthetized rat spinal cord.

27 October 2022

28

1 reference

https://api.crossref.org/works/10.1016/0143-4179(91)90087-Y

Cholecystokinin octapeptide antagonized opioid analgesia mediated by mu- and kappa- but not delta-receptors in the spinal cord of the rat.

27 October 2022

29

1 reference

https://api.crossref.org/works/10.1016/0143-4179(91)90087-Y

Chronic administration of cholecystokinin antagonists reverses the enhancement of spinal morphine analgesia induced by acute pretreatment

27 October 2022

30

1 reference

https://api.crossref.org/works/10.1016/0143-4179(91)90087-Y

Evidence for an involvement of the brain cholecystokinin B receptor in anxiety

27 October 2022

31

1 reference

https://api.crossref.org/works/10.1016/0143-4179(91)90087-Y

The behavioural properties of CI-988, a selective cholecystokininB receptor antagonist

27 October 2022

32

1 reference

https://api.crossref.org/works/10.1016/0143-4179(91)90087-Y

27 October 2022

Identifiers

1 reference

14 August 2017

1 reference